Charles S. Fuchs's most recent trade in CytomX Therapeutics Inc was a trade of 20,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
CytomX Therapeutics Inc | Charles S. Fuchs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |